BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36601892)

  • 21. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M
    More-Adate P; Lokhande KB; Swamy KV; Nagar S; Baheti A
    Comput Biol Med; 2022 Aug; 147():105679. PubMed ID: 35667152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations.
    Skariyachan S; Muddebihalkar AG; Badrinath V; Umashankar B; Eram D; Uttarkar A; Niranjan V
    Infect Genet Evol; 2020 Aug; 82():104314. PubMed ID: 32268193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
    Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
    Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring inhibitory potential of Curcumin against various cancer targets by in silico virtual screening.
    Mahajanakatti AB; Murthy G; Sharma N; Skariyachan S
    Interdiscip Sci; 2014 Mar; 6(1):13-24. PubMed ID: 24464700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies.
    Hassan M; Azhar M; Abbas Q; Raza H; Moustafa AA; Shahzadi S; Ashraf Z; Seo SY
    Curr Comput Aided Drug Des; 2018; 14(2):160-173. PubMed ID: 29332600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting
    Altharawi A
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
    Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
    Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aphrodisiac Performance of Bioactive Compounds from
    Palanichamy C; Pavadai P; Panneerselvam T; Arunachalam S; Babkiewicz E; Ram Kumar Pandian S; Shanmugampillai Jeyarajaguru K; Nayak Ammunje D; Kannan S; Chandrasekaran J; Sundar K; Maszczyk P; Kunjiappan S
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
    Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
    Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.
    Ballav S; Lokhande KB; Yadav RS; Ghosh P; Swamy KV; Basu S
    Mol Divers; 2023 Dec; 27(6):2867-2885. PubMed ID: 36544031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
    Tabassum H; Ahmad IZ
    Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Insight from Computational Virtual Screening Depict the Binding Potential of Selected Phytotherapeutics Against Probable Drug Targets of Clostridium difficile.
    Kamath S; Skariyachan S
    Interdiscip Sci; 2018 Sep; 10(3):583-604. PubMed ID: 28217823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
    Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
    Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation.
    Elekofehinti OO; Iwaloye O; Molehin OR; Famusiwa CD
    In Silico Pharmacol; 2021; 9(1):49. PubMed ID: 34395160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.